Literature DB >> 23783751

Report of stroke-like symptoms predicts incident cognitive impairment in a stroke-free cohort.

Brendan J Kelley1, Leslie A McClure, Abraham J Letter, Virginia G Wadley, Frederick W Unverzagt, Brett M Kissela, Dawn Kleindorfer, George Howard.   

Abstract

OBJECTIVE: The present study characterizes the relationship between report of stroke symptoms (SS) or TIA and incident cognitive impairment in the large biracial cohort of the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
METHODS: The REGARDS Study is a population-based, biracial, longitudinal cohort study that has enrolled 30,239 participants from the United States. Exclusion of those with baseline cognitive impairment, stroke before enrollment, or incomplete data resulted in a sample size of 23,830. Participants reported SS/TIA on the Questionnaire for Verifying Stroke-free Status at baseline and every 6 months during follow-up. Incident cognitive impairment was detected using the Six-item Screener, which was administered annually.
RESULTS: Logistic regression found significant association between report of SS/TIA and subsequent incident cognitive impairment. Among white participants, the odds ratio for incident cognitive impairment was 2.08 (95% confidence interval: 1.81, 2.39) for those reporting at least one SS/TIA compared with those reporting no SS/TIA. Among black participants, the odds ratio was 1.66 (95% confidence interval: 1.45, 1.89) using the same modeling. The magnitude of impact was largest among those with fewer traditional stroke risk factors, particularly among white participants.
CONCLUSIONS: Report of SS/TIA showed a strong association with incident cognitive impairment and supports the use of the Questionnaire for Verifying Stroke-free Status as a quick, low-cost instrument to screen for people at increased risk of cognitive decline.

Entities:  

Mesh:

Year:  2013        PMID: 23783751      PMCID: PMC3770175          DOI: 10.1212/WNL.0b013e31829a352e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Vascular risk factors and cognitive impairment in a stroke-free cohort.

Authors:  F W Unverzagt; L A McClure; V G Wadley; N S Jenny; R C Go; M Cushman; B M Kissela; B J Kelley; R Kennedy; C S Moy; V Howard; G Howard
Journal:  Neurology       Date:  2011-11-08       Impact factor: 9.910

2.  Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group.

Authors:  T R Price; T A Manolio; R A Kronmal; S J Kittner; N C Yue; J Robbins; H Anton-Culver; D H O'Leary
Journal:  Stroke       Date:  1997-06       Impact factor: 7.914

3.  Self-reported stroke symptoms without a prior diagnosis of stroke or transient ischemic attack: a powerful new risk factor for stroke.

Authors:  Dawn Kleindorfer; Suzanne Judd; Virginia J Howard; Leslie McClure; Monika M Safford; Mary Cushman; David Rhodes; George Howard
Journal:  Stroke       Date:  2011-09-15       Impact factor: 7.914

4.  Silent MRI infarcts and the risk of future stroke: the cardiovascular health study.

Authors:  C Bernick; L Kuller; C Dulberg; W T Longstreth; T Manolio; N Beauchamp; T Price
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

5.  Vascular risk factors and longitudinal changes on brain MRI: the ARIC study.

Authors:  D S Knopman; A D Penman; D J Catellier; L H Coker; D K Shibata; A R Sharrett; T H Mosley
Journal:  Neurology       Date:  2011-05-04       Impact factor: 9.910

6.  Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination.

Authors:  W J Jones; L S Williams; J F Meschia
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

Review 7.  Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Manjula Kurella Tamura; Virginia Wadley; Kristine Yaffe; Leslie A McClure; George Howard; Rodney Go; Richard M Allman; David G Warnock; William McClellan
Journal:  Am J Kidney Dis       Date:  2008-06-30       Impact factor: 8.860

8.  Association of higher diastolic blood pressure levels with cognitive impairment.

Authors:  G Tsivgoulis; A V Alexandrov; V G Wadley; F W Unverzagt; R C P Go; C S Moy; B Kissela; G Howard
Journal:  Neurology       Date:  2009-08-25       Impact factor: 9.910

9.  Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study.

Authors:  Sarah E Vermeer; Monika Hollander; Ewoud J van Dijk; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  Stroke       Date:  2003-04-10       Impact factor: 7.914

10.  Six-item screener to identify cognitive impairment among potential subjects for clinical research.

Authors:  Christopher M Callahan; Frederick W Unverzagt; Siu L Hui; Anthony J Perkins; Hugh C Hendrie
Journal:  Med Care       Date:  2002-09       Impact factor: 2.983

View more
  9 in total

1.  Racial Differences in Neurocognitive Outcomes Post-Stroke: The Impact of Healthcare Variables.

Authors:  Neco X Johnson; Maria J Marquine; Ilse Flores; Anya Umlauf; Carolyn M Baum; Alex W K Wong; Alexis C Young; Jennifer J Manly; Allen W Heinemann; Susan Magasi; Robert K Heaton
Journal:  J Int Neuropsychol Soc       Date:  2017-06-29       Impact factor: 2.892

2.  Regular aspirin use does not reduce risk of cognitive decline.

Authors:  Brendan J Kelley; Leslie A McClure; Frederick W Unverzagt; Brett Kissela; Dawn Kleindorfer; George Howard; Virginia G Wadley
Journal:  J Am Geriatr Soc       Date:  2015-02       Impact factor: 5.562

3.  N-Terminal pro-B-type natriuretic peptide and stroke risk across a spectrum of cerebrovascular disease: The REasons for Geographic and Racial Differences in Stroke cohort.

Authors:  Kara K Landry; Suzanne E Judd; Dawn O Kleindorfer; George Howard; Virginia J Howard; Neil A Zakai; Mary Cushman
Journal:  Res Pract Thromb Haemost       Date:  2020-06-14

4.  Performance of the NINDS-CSN 5-minute protocol in a national population-based sample.

Authors:  Richard E Kennedy; Virginia G Wadley; Leslie A McClure; Abraham J Letter; Frederick W Unverzagt; Michael Crowe; David Nyenhius; Brendan J Kelley; Bhumika Kana; Janice Marceaux; Manjula Kurella Tamura; Virginia Howard; George Howard
Journal:  J Int Neuropsychol Soc       Date:  2014-08-28       Impact factor: 2.892

5.  Stroke Symptoms With Absence of Recognized Stroke Are Associated With Cognitive Impairment and Depressive Symptoms in Older Adults With Diabetes.

Authors:  Jesse S Passler; Olivio J Clay; Virginia G Wadley; Fernando Ovalle; Michael Crowe
Journal:  J Geriatr Psychiatry Neurol       Date:  2016-01-21       Impact factor: 2.680

6.  Stroke symptoms and risk for incident coronary heart disease in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Lisandro D Colantonio; Christopher M Gamboa; Dawn O Kleindorfer; April P Carson; Virginia J Howard; Paul Muntner; Mary Cushman; George Howard; Monika M Safford
Journal:  Int J Cardiol       Date:  2016-06-14       Impact factor: 4.164

Review 7.  Cardiovascular disease risk models and longitudinal changes in cognition: a systematic review.

Authors:  Stephanie L Harrison; Jie Ding; Eugene Y H Tang; Mario Siervo; Louise Robinson; Carol Jagger; Blossom C M Stephan
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

8.  Association of frequent premature ventricular complex >10% and stroke-like symptoms without a prior diagnosis of stroke or transient ischemic attack.

Authors:  Sung Il Im; Seok Hyun Kim; Bong Joon Kim; Kyoung Im Cho; Hyun Su Kim; Jung Ho Heo
Journal:  Int J Cardiol Heart Vasc       Date:  2018-05-10

9.  Atrial Fibrillation and Stroke Symptoms in the REGARDS Study.

Authors:  Meghan Reading Turchioe; Elsayed Z Soliman; Parag Goyal; Alexander E Merkler; Hooman Kamel; Mary Cushman; Orysya Soroka; Ruth Masterson Creber; Monika M Safford
Journal:  J Am Heart Assoc       Date:  2022-01-13       Impact factor: 6.106

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.